[4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone

C20H17F2N7O2 — CID 91073181

IUPAC[4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone
SMILESO=C(c1ccc(Nc2nc3c(-c4cnn(C(F)F)c4)cccn3n2)cc1)N1CC(O)C1
InChIInChI=1S/C20H17F2N7O2/c21-19(22)29-9-13(8-23-29)16-2-1-7-28-17(16)25-20(26-28)24-14-5-3-12(4-6-14)18(31)27-10-15(30)11-27/h1-9,15,19,30H,10-11H2,(H,24,26)
InChIKeyVKORKRIBJRWMTR-UHFFFAOYSA-N
MW425.40 g/mol
LogP2.55
Rot. Bonds5

About [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone

[4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone (PubChem CID 91073181) has the molecular formula C20H17F2N7O2 and a molecular weight of 425.40 g/mol. Its IUPAC name is [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone.

Molecular Properties

Compound Name[4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone
PubChem CID91073181
Molecular FormulaC20H17F2N7O2
Molecular Weight425.40 g/mol
Exact Mass425.14
IUPAC Name[4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone
SMILESO=C(c1ccc(Nc2nc3c(-c4cnn(C(F)F)c4)cccn3n2)cc1)N1CC(O)C1
InChIInChI=1S/C20H17F2N7O2/c21-19(22)29-9-13(8-23-29)16-2-1-7-28-17(16)25-20(26-28)24-14-5-3-12(4-6-14)18(31)27-10-15(30)11-27/h1-9,15,19,30H,10-11H2,(H,24,26)
InChIKeyVKORKRIBJRWMTR-UHFFFAOYSA-N
XLogP2.55
TPSA100.58 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500425.40
LogP ≤ 52.55
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone?
The IUPAC name of [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone (CID 91073181) is [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone.
What is the SMILES notation for [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone?
The canonical SMILES for [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone is O=C(c1ccc(Nc2nc3c(-c4cnn(C(F)F)c4)cccn3n2)cc1)N1CC(O)C1.
What is the InChIKey of [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone?
The InChIKey is VKORKRIBJRWMTR-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H17F2N7O2/c21-19(22)29-9-13(8-23-29)16-2-1-7-28-17(16)25-20(26-28)24-14-5-3-12(4-6-14)18(31)27-10-15(30)11-27/h1-9,15,19,30H,10-11H2,(H,24,26).
What are the key properties of [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone?
[4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone has a molecular weight of 425.40 g/mol, XLogP of 2.55, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[8-[1-(difluoromethyl)pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-(3-hydroxyazetidin-1-yl)methanone is sourced from PubChem (CID 91073181), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).